McDermott International and CB&I announced on Monday that they had agreed to combine in an all-stock transaction to create a fully integrated onshore-offshore company, with a broad engineering, procurement, construction, and installation (EPCI) service offering and a market-leading technology portfolio.
On a proforma basis, McDermott and CB&I would have combined revenue of approximately $10 billion and a backlog of approximately $14.5 billion.
On completion of the transaction, McDermott shareholders will own approximately 53% of the combined company and CB&I shareholders will own the rest. The estimated enterprise value of the transaction is approximately $6 billion, based on the closing share price of McDermott on 15 December.
The transaction has been approved by the board of each company and is expected to be completed in the second quarter of 2018. It remains subject to antitrust approvals, and approval by McDermott and CB&I shareholders as well as other customary closing conditions.
The move follows CB&I’s decision earlier this year to seek ways to improve financial performance, including the possible divestment of the company’s large technology portfolio. “Customers worldwide increasingly seek a single company that can offer end-to-end solutions, and the combination of McDermott and CB&I responds to these evolving customer needs by creating a leading vertically integrated company. This transaction combines two highly complementary businesses to create a leading onshore-offshore EPCI company driven by technology and innovation, with the scale and diversification to better capitalize on global growth opportunities,” says David Dickson, president and CEO of McDermott. “This unique opportunity to combine with McDermott was presented as we pursued the sale of our technology and former engineered products businesses. Our supervisory and management boards and our management team reviewed multiple strategic options and we ultimately decided this transaction is the best path forward and in the best interest of CB&I, and its shareholders and other stakeholders,” says Patrick Mullen, president and CEO of CB&I.
The combination will unite McDermott’s established presence in the Middle East and Asia with CB&I’s operations in the United States, creating a balanced geographic portfolio with a strong position in high-growth developing regions. It will create opportunities to capture additional value across the entire value chain, the companies say. McDermott and CB&I will have a presence across onshore and offshore, upstream, downstream, and power markets.
By retaining CB&I’s technology business, the combined company will be one of the largest providers of licensed process technologies. McDermott and CB&I anticipate leveraging these capabilities across their customer base to drive follow-on work.
The transaction is expected to be cash accretive, excluding one-time costs, within the first year after closing. It is also expected to generate synergies leading to annualized cost savings of $250 million in 2019. This is in addition to a $100-million cost-reduction program that CB&I expects to have fully implemented by the end of 2017.
The combined company will be headquartered in the Houston area. David Dickson, current president and CEO of McDermott, will be president and CEO of the combined company, and Stuart Spence, current executive vice president and CEO of McDermott, will be executive vice president and CFO of the combined company. Patrick Mullen, president and CEO of CB&I, will remain with the combined company for a transition period to ensure a seamless integration.
The combined company has secured approximately $6 billion of fully committed financing, led by Barclays, Credit Agricole CIB, and Goldman Sachs, and it is expected that permanently funded debt financing in the form of term loans and unsecured bonds will be put into place prior to closing.
By Natasha Alperowicz
Source: Chemical Week
Corteva (Indianapolis, Indiana) says it has signed a definitive agreement to acquire Stoller Group (Houston, Texas), a producer of biostimulants and plant nutrition products, for $1.2 billion. Stoller is one of the largest independent biologicals companies globally, with operations in more than 60 countries and more than $400 million in annual sales.
OMV has announced its new corporate structure today, designed to fully enable the delivery of Strategy 2030. The new organization will be built on five distinct areas. In addition to the CEO and CFO areas, three business segments will be established: Chemicals & Materials, Fuels & Feedstock, and Energy.
The European petchem sector is readying for some tough quarters. It’s a different picture in the US. So is this the best time ever to find a new role in the chemical industry? If you are in Europe, you would expect me to say probably not. But actually, it depends. So let me give you four answers to this question.